Radiotherapy UK
- Advocating to improve access to high quality radiotherapy treatment across the UK.- Developing patient information packages - Supporting skills and knowledge development of radiotherapy workforce
Financial health, per its FY2025 accounts
The accounts state that the charity generated a net profit of £12,953 for the year, with total income of £214,611 and expenditure of £201,658. The trustees report that the charity is confident in securing future funding despite economic constraints, and there are no material uncertainties regarding its ability to continue as a going concern.
What the accounts disclose
“Radiotherapy UK’s policy is to provide the charity with adequate financial stability and the means for it to meet its charitable objectives. Except for such funds as the Trustees consider prudent to maintain for the purposes of management and administration of the charity for the foreseeable future, all unrestricted funds are used to the purpose of general objects of the charity.”
“During the year there was a further £2,374 (2024: £4,676) paid to Professor Pat Price Limited. These were for general administrative costs.” — page 18
“The charity received an interest-free loan from Price Jones Limited, a company in which one of the trustees Professor Patricia Price is a director and shareholder. The loan currently stands at £12,672 and is repayable at £2,500 per annum beginning 1 July 2017.” — page 18
“During the year there was a further £2,374 (2024: £4,676) paid to Professor Pat Price Limited. These were for general administrative costs.” — page 18
“The charity received an interest-free loan from Price Jones Limited, a company in which one of the trustees Professor Patricia Price is a director and shareholder. The loan currently stands at £12,672 and is repayable at £2,500 per annum beginning 1 July 2017.” — page 18
“During the year there was a further £2,374 (2024: £4,676) paid to Professor Pat Price Limited. These were for general administrative costs.” — page 18
“The charity received an interest-free loan from Price Jones Limited, a company in which one of the trustees Professor Patricia Price is a director and shareholder. The loan currently stands at £12,672 and is repayable at £2,500 per annum beginning 1 July 2017.” — page 18
“During the year there was a further £2,374 (2024: £4,676) paid to Professor Pat Price Limited. These were for general administrative costs.” — page 18
“The charity received an interest-free loan from Price Jones Limited, a company in which one of the trustees Professor Patricia Price is a director and shareholder. The loan currently stands at £12,672 and is repayable at £2,500 per annum beginning 1 July 2017.” — page 18
“During the year there was a further £2,374 (2024: £4,676) paid to Professor Pat Price Limited. These were for general administrative costs.” — page 18
Trustees
- PROF PATRICIA PRICEchair
- Adele Lyons
- Andy Tudor
- Dr Christy Goldsmith
- Dr Clare Louise Hague
- Dr William Philip MAYLES
- Professor Andrew Beavis
- Samina Hussain
- TANYA PERSEY
- VICTORIA CHAPMAN
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 22/06/2025 | £215k | £202k |
| 22/06/2024 | £117k | £163k |
| 22/06/2023 | £129k | £113k |
| 22/06/2022 | £174k | £92k |
| 22/06/2021 | £111k | £43k |
Common questions
Is Radiotherapy UK financially healthy?
Per its FY2025 accounts: The accounts state that the charity generated a net profit of £12,953 for the year, with total income of £214,611 and expenditure of £201,658. The trustees report that the charity is confident in securing future funding despite economic constraints, and there are no material uncertainties regarding its ability to continue as a going concern. Its FY2025 accounts were independently examined.